Josep Gumà-Padrò

16PUBLICATIONS
73CO-AUTHORS
Predictive and prognostic markersHumoural immunology and immunochemistryHaematological tumoursMedical biochemistry - amino acids and metabolitesMetabolic medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Sep 28, 2026
Prognostic value of PD-L1 in patients with metastatic renal cell carcinoma (mRCC) treated with antiangiogenic first line drugs (PROANG-SOGUG study).

|Oct 23, 2025
SEOM-GOTEL clinical guidelines on diffuse large B-cell lymphoma (update 2025).

Josep Gumà, Natalia Palazón-Carrión, Antonio Rueda-Domínguez

|Oct 08, 2025
Performance and safety of Femorally Inserted Central Catheters in oncological patients: A cases series analysis.

María Teresa Parejo Arrondo, Berta Griso Jurado, Lourdes Bayona Escat

|Feb 13, 2025
Ketone Bodies Are Potential Prognostic Biomarkers in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Results from the R2-GDP-GOTEL Trial.

Sara Fernández-Castillejo, Joan Badia, Luís de la Cruz-Merino

|Mar 13, 2024
Easy-Amanida: An R Shiny application for the meta-analysis of aggregate results in clinical metabolomics using Amanida and Webchem.

Maria Llambrich, Pau Satorra, Eudald Correig

|Dec 22, 2023
A Metabolites Merging Strategy (MMS): Harmonization to Enable Studies' Intercomparison.

Héctor Villalba, Maria Llambrich, Josep Gumà

Pageof 3

Frequent Collaborators

5 joint publications

Marta Rodríguez-Balada

3 joint publications

Joan Badia

3 joint publications

Mariano Provencio-Pulla

3 joint publications

Margarita Sánchez-Beato